UnknownNot Applicable

Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids

China30 participantsStarted 2016-05

Plain-language summary

This study evaluates corticosteroids in the treatment of obstructive jaundice in autoimmune pancreatitis and/or immunoglobulin G4 (IgG4)-related sclerosing cholangitis in adults. Half of participants will receive corticosteroids alone, while the other half will receive corticosteroids with biliary stent at the beginning.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * adults greater than 18 years-old; * autoimmune pancreatitis and/or IgG4-related sclerosing cholangitis; * obstructive jaundice Exclusion Criteria: * malignancies; active infections; * pregnancy or breast feeding; * standard contraindications to ERCP; * unwillingness or inability to consent for the study

What they're measuring

Clinical remission rate of obstructive jaundice

Timeframe: Day 60

Trial details

NCT IDNCT02797665

SponsorPeking Union Medical College Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-12

Contact for this trial

Aiming Yang, M.D.

+86-10-69151593 yangaiming@medmail.com.cn

View on ClinicalTrials.gov More Autoimmune Pancreatitis trials